NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

TC Trader,

The manufacturing ramp up is one of the keys to approval for both L and Direct in my opinion. Direct may also be in the process of being improved upon even more. I believe NWBO may be working to achieve higher concentrations of a DC subset in Direct that is associated with better patient outcomes. This would also need to fit into the fully automated process they are working on. The delay of Phase 2 may be the price paid for the next trial to be shorter and the last one they need to run before potential approval.